January 27, 2009
The moment of truth is close in determining the winner of the battle for the RFID pharmaceutical market. While the FDA has not and probably will not back one frequency or technology over another California’s ePedigree mandate will provide the market with the de facto standard UHF or HF. California’s 2009 ePedigree mandate for all drug packages coming into the state explicitly requires package serialization…can you say RFID? All of the major drug distributors AmerisourceBergen, McKesson and Cardinal Health are scaling up to met the mandate. The distributors, while they will not declare the winner being UHF or HF, are either testing both HF and UHF or only UHF – another sign UHF will probably win.
The impact of using RFID tags at the item level for the pharmaceutical market will finally provide the hockey stick demand curve the industry has been waiting for. So all of us in the RFID business will be watching the success or failure of the RFID California mandate very closely.
I would like to reference a very good article on this topic of UHF vs. HF (California RFID Mandate). The performance of RFID Readers and RFID Tags as well as the cost seems to be in favor of UHF so it will interesting to see who will win.